doi: 10.1161/hy0202.102835
(Hypertension. 2002;39:449.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
Lipocalin-Type Prostaglandin D Synthase in Essential Hypertension
From the Department of Medicine #2, Yokohama City University (N.H., Y.T., S.U.), Japan; Health Service Center and Department of Medicine #2, University of Tokyo (Y.Ue.), Japan; Health Service Center Mitsui Hospital (M.Y.), Tokyo, Japan; Department of Nephrology, Kanto Medical Center NTT (T.G., T.I.), Tokyo, Japan; Intensive Care Unit, Shiga University of Medical Science (Y.E.), Otsu, Japan; Department of Medicine, Tokyo Police Hospital (M.T.), Tokyo, Japan; Biochemistry Research Laboratory, Central Research Institute, Maruha Corporation (H.O., K.S.), Tsukuba, Japan; Department of Molecular Behavioral Biology, Osaka Bioscience Institute (Y.Ur.), Osaka, Japan.
Correspondence to Yoshio Uehara, MD, Health Service Center and Department of Medicine #2, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan. E-mail uehara-2im{at}h.u-tokyo.ac.jp
Lipocalin-type prostaglandin D synthase (L-PGDS) reportedly well predicts cardiovascular injuries in humans. However, little is known about the implications of L-PGDS in hypertension. In the present study, we investigated the alterations of serum and urinary L-PGDS in hypertensive patients with or without renal dysfunction. A total of 111 patients with hypertension (EHT; 65 with normoalbuminuria, 23 with microalbuminuria, 12 with macroalbuminuria, 11 with renal failure) and 102 normotensive, nomoalbuminuric subjects (NT) were studied. L-PGDS was measured by enzyme-linked immunosorbent assay, and L-PGDS in the kidney was localized using immunohistochemical methods. Blood pressure was higher in EHT groups than in the NT group (P<0.0001). There were no differences in age, gender, BMI, TC, TG, and HbA1c levels among the groups. Serum creatinine and urinary albumin levels were higher in the group with renal failure. Serum levels of L-PGDS were increased in EHT with normoalbuminuria, as compared with NT (0.88±0.05 versus 0.65±0.02 µg/mL; P<0.001). Serum levels of L-PGDS increased with the renal function worsened and positively correlated with serum creatinine, particularly in patients with renal impairments (r=0.76, P<0.0001). Similarly, the urinary L-PGDS excretions in EHT with normoalbuminuria were higher than that in NT (2.31±0.29 versus 1.16±0.14 mg/gCr, P<0.001), whereas there were no differences in urinary albumin excretion between the 2 groups. Moreover, urinary L-PGDS excretion increased dramatically with an increase in albuminuria or proteinuria. L-PGDS was stained in the tubules and the interstitium of the kidney in nephrosclerosis. In conclusion, patients with hypertension exhibited a higher level of L-PGDS in serum and urine, and this became increasingly obvious along with advance in renal dysfunction. These data suggest that L-PGDS metabolism is related to blood pressure and kidney injuries associated with hypertension.
Key Words: prostaglandins • hypertension, essential • renal injury • albuminuria • blood pressure
This article has been cited by other articles:
 |
|
 |
|
  Y. Uehara, H. Makino, K. Seiki, Y. Urade, and on behalf of L-PGDS Clinical Research Group of Kid Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study Nephrol. Dial. Transplant., February 1, 2009; 24(2): 475 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Qi, H. Cai, J. D. Morrow, and M. D. Breyer Differentiation of Cyclooxygenase 1- and 2-Derived Prostanoids in Mouse Kidney and Aorta Hypertension, August 1, 2006; 48(2): 323 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ogawa, N. Hirawa, T. Tsuchida, N. Eguchi, Y. Kawabata, A. Numabe, H. Negoro, R. Hakamada-Taguchi, K. Seiki, S. Umemura, et al. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats Nephrol. Dial. Transplant., April 1, 2006; 21(4): 924 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujimori, K. Kadoyama, and Y. Urade Protein Kinase C Activates Human Lipocalin-type Prostaglandin D Synthase Gene Expression through De-repression of Notch-HES Signaling and Enhancement of AP-2{beta} Function in Brain-derived TE671 Cells J. Biol. Chem., May 6, 2005; 280(18): 18452 - 18461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miyagi, Y. Miwa, F. Takahashi-Yanaga, S. Morimoto, and T. Sasaguri Activator Protein-1 Mediates Shear Stress-Induced Prostaglandin D Synthase Gene Expression in Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 970 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ragolia, T. Palaia, T. B. Koutrouby, and J. K. Maesaka Inhibition of cell cycle progression and migration of vascular smooth muscle cells by prostaglandin D2 synthase: resistance in diabetic Goto-Kakizaki rats Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1273 - C1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Otsuki, H. Gao, K. Dahlman-Wright, C. Ohlsson, N. Eguchi, Y. Urade, and J.-A. Gustafsson Specific Regulation of Lipocalin-Type Prostaglandin D Synthase in Mouse Heart by Estrogen Receptor {beta} Mol. Endocrinol., September 1, 2003; 17(9): 1844 - 1855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ragolia, T. Palaia, E. Paric, and J. K. Maesaka Prostaglandin D2 Synthase Inhibits the Exaggerated Growth Phenotype of Spontaneously Hypertensive Rat Vascular Smooth Muscle Cells J. Biol. Chem., June 6, 2003; 278(24): 22175 - 22181. [Abstract] [Full Text] [PDF]
|
|